You need to enable JavaScript to run this app.
Recon: FDA Approves Two Paratek Antibiotics; Boston Pharma Licenses Eight Drugs from GSK, Novartis
Recon
Michael Mezher
ReconMichael Mezher
ReconMichael Mezher